BAC Warns of Q3 Capital Markets Weakness: Will Fee Income Take a Hit?

Bank of America expects Q3 2026 investment-banking fees of $1.6-$1.8 billion, implying a roughly 15% year-over-year decline at the midpoint and about a 20% sequential drop from $2.14 billion in Q2. Sales and trading revenue is expected to remain roughly flat near $5.36 billion, putting combined IB and trading revenue at $6.96-$7.16 billion versus $7.36 billion a year earlier. Higher wealth-management AUM fees, projected to rise 10-15%, should partly offset capital-markets weakness, though $18.6 billion of expected expenses could pressure operating leverage. Management characterized the deal pipeline as very strong, indicating the slowdown may be timing-related rather than structural.

Analysis

BAC's issue is not merely lower fee revenue; it is unfavorable operating leverage. A capital-markets shortfall against a largely fixed quarterly expense base can create disproportionate EPS downside and reduce the probability of a near-term ROTCE re-rating. The read-through is most negative for universal banks with meaningful prime brokerage and financing exposure, while C's comparatively stronger markets mix suggests a potential share-gain or product-mix advantage rather than an industry-wide activity collapse.

The divergence between BAC and C also matters for estimates: if C delivers positive markets/IB growth while BAC misses, investors will likely assign the weakness to execution, client mix, or share rather than macro timing. That raises the risk that BAC's lower tangible-book multiple is a value trap over the next 1-3 months, despite its longer-term asset sensitivity and wealth-fee offset. The key falsifier is a better-than-guided trading result or evidence that announced/pending transactions convert before quarter-end; either would limit the negative operating-leverage surprise.

Contrarian case: management's commentary may deliberately set a low bar, and the market should not extrapolate one quarter of financing softness into a multi-quarter downturn if the advisory pipeline is real. Over 6-18 months, a revival in M&A and debt issuance would disproportionately benefit BAC because incremental advisory/trading revenue carries high contribution margins once expenses are absorbed. The more attractive structural risk is therefore not an outright BAC short, but expressing the near-term revenue-mix divergence against C while preserving upside to a normalization in industry activity.

Key Decisions for Investors

• Initiate a 1-3 month relative-value trade: long C / short BAC, dollar-neutral. Target 5-8% relative outperformance through earnings as C's markets and IB trajectory contrasts with BAC's operating-leverage risk; exit if BAC raises its combined markets outlook or C reduces its growth outlook.
• Avoid adding outright BAC exposure ahead of earnings unless consensus EPS has already been reduced for the lower capital-markets run rate. Reassess after results for evidence that wealth fees fully offset the shortfall and that the expense run rate is controllable.
• For existing BAC longs, buy short-dated downside protection around the earnings date rather than selling the strategic position. The risk event is a fee-income/expense mismatch and forward-guide reset; protection can be removed if trading revenue exceeds the guided flat trajectory.
• Maintain KEY as a separate regional-bank/NII expression rather than using it as a direct BAC hedge. Its revised revenue outlook is driven more by balance-sheet income and non-interest-income execution; the thesis fails if deposit costs reaccelerate or NII guidance is cut.